Epitopea

Revealing Novel Targets For Next Generation Immunotherapies

Epitopea is a transatlantic cancer immunotherapeutics company with headquarters in Montreal (Canada) and Cambridge (UK), using a proprietary CryptoMapTM platform.

Partnerships